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Abstract
Establishing realistic exposure scenarios is critical for cytotoxic investigation of silver (Ag)
nanoparticles in the gastrointestinal tract. This study investigated the potential interaction with and
effect of biofluid components, namely cholic acid, deoxycholic acid and ursodeoxycholic acid, on
AgNP toxicity. Two cell lines corresponding to organs related to the biofluid components were
employed. These were HepG-2 a hepatocellular carcinoma derived from liver tissue and Hep2 an
epithelial cell line. Physiochemical and cytotoxic screening was performed and the ability of
biofluid components to modify AgNP cytotoxicity was explored. No alteration to the
physiochemical characteristics of AgNP by biofluid components was demonstrated. However,
biofluid component addition resulted in alteration of AgNP toxicity. Greater ROS induction was
noted in the presence of CA and DCA. UDCA demonstrated no modification of toxicity in HEpG2 cells however significant modification was noted in Hep2 cells. It is concluded that biofluid
components can modify AgNP toxicity but this is dependent on the biofluid component itself and
the location where it acts.

Short Abstract
Silver nanoparticle (AgNP) interaction with biofluids upon entry to the body is important for
accurate toxicological investigation. A number of toxicological tests were performed and
demonstrated modification of AgNP toxicity by the chosen biofluid components cholic acid,
deoxycholic acid and ursodeoxycholic acid. It is concluded that the influence on AgNP toxicity by
biofluid components is dependent on the biofluid component itself and the location where it acts.

Introduction
Nanotechnology has been described as a new frontier in science and technology with many
different applications in fields including textiles, electronics, medicine, cosmetics and food (Sozar
& Kokini, 2009; Bouwmeester et al, 2009). Silver (AgNP) nanoparticles in particular are
becoming the material of choice for incorporation into consumer goods mainly due to their
antimicrobial properties (Choi et al, 2008). Compared to bulk silver, nanosilver displays different
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physiochemical properties due to its size and increased surface area including increased photonics
and catalytic properties as well as enhanced antimicrobial activity (Choi et al, 2008; Poda et al,
2011; Zhai et al, 2006).
When considering nanoparticle exposure it is important to take into account not only the route of
entry to the body but also the various biological systems, biofluids and surfactants they will
encounter. Indeed as a result of the potential interaction with the various components of bio-fluids,
nanoparticles may be affected ultimately changing how they interact with cells and the responses
they evoke.
With the ever increasing use of nanoparticles in food products and with new EU legislation
enforcing that all forms of engineered nanoparticles present in food must be stated on food
packaging, “nano-labeling” coming into effect in December 2014, it is now more crucial than ever
that the interaction between nanoparticles and living systems is thoroughly investigated (Nano and
other Emerging Technologies Blog, 2013). In particular, the potential toxic effect of nanoparticles
to the gastrointestinal tract and their interactions with various biofluids associated with this system
must be determined.
The gastrointestinal tract has been noted as a major area of AgNP deposition coupled with
pathological responses. A number of studies have demonstrated damaged microvilli and intestinal
glands, abnormal pigmentation and an increase in intestinal goblet cells following oral
administration of AgNP in rats (Hadrup & Lam, 2014; Shahare & Yashpal, 2013; Jeong et al,
2010; Kim et al, 2010). The liver in particular is an important site of nanoparticle deposition
following oral ingestion with reports of high concentrations of AgNP reported in mice 24 hours
after exposure. Inhalation also provides a route to the liver. Mucocilliary clearance of nanoparticles
can result in entry to the GI tract and deposition in the liver. Accumulation of AgNP can lead to
liver toxicity including bile duct hyperplasia and inflammation (Kim et al, 2008; Nemmar et al,
2002). The liver has also been identified as a one of the main pathways involved in nanoparticle
excretion. Hepato-biliary secretion is believed to be a main route of intestinal secretion of
nanoparticles with evidence of gold and polystyrene nanoparticle excretion by this route.
Accumulation of nanoparticles within bile canaliculi is suggestive of the important role of bile in
the intestinal secretion and elimination of nanoparticles in faeces (Zhao et al, 2014; Johnston et al,
2010; Semmler-Behnke et al, 2008).

A biofluid is any fluid originating from within the body that can be excreted, secreted, obtained by
a needle or can develop due to a pathological process and ranges from blood to bile and breast
milk to cyst fluid (Medicinenet). It has been shown that certain biofluids and surfactants can aid
the processing of nanoparticles and can isolate nanoparticles from larger agglomerates by coating
the particle or modifying its surface chemistry (Herzog et al, 2009). Interactions with various
surfactants including biological surfactants and fluids can result in adsorption of a variety of
different molecules and proteins onto the surface of nanoparticles. As a result many studies have
shown that this “coating” can affect how a nanoparticle interacts with the biological environment.
These affects range from changes in the particle itself such as ion release and changes in
morphology to the responses it induces and where it is trafficked within the body (Herzog et al,
2009; Mwilu et al, 2013; Ehrenberg et al, 2009; Wang et al, 2013; Misra et al, 2012; Aggarwal et
al, 2009). It is this ability of biofluids to interact and process foreign bodies in the human body
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that make them integral to the defence systems of the body. In this study three components of bile
were chosen and are referred to as biofluid components throughout as they were studied
individually. The biofluid components employed were cholic acid (CA), deoxycholic acid (DCA)
and ursodeoxycholic acid (UDCA).
Bile salts are organic solutes synthesized from cholesterol by hepatocytes (Kumar & Bohidar,
2010; Perez & Briz, 2009). Cholic acid is one of the major primary bile acids in the liver and is
synthesized from cholesterol and constitutes about 30-40% of bile acids (Debruyne et al, 2001).
Formation of these bile acids is important in cholesterol homeostasis. Deoxycholic acid is a
secondary bile acid and constitutes roughly 10-40% of total bile (Marcus & Heaton, 1988). DCA
has also been demonstrated to promote colonic epithelium proliferation (Deschner et al, 1981;
Ochsenkuhn et al, 1999). UDCA is a secondary bile acid comprising 3% of total bile acids (Perez
& Briz, 2009). Despite its low abundance it has been shown to have direct antioxidant properties
especially against hydroxyl radicals and can also prevent the retention of certain toxic hydrophobic
bile acids. UDCA has also a number of therapeutic applications including dissolving gall stones
and as an alternative therapy for hepatitis C patients in place of interferon therapy (Arisawa et al,
2009; Lapenna et al, 2002). This particular bile acid has also shown promise as a potential targeted
therapy for colorectal cancer (Debruyne et al, 2001).
This study aims to demonstrate if biofluid components can mediate nanoparticle toxicity. Their
incorporation may enhance or reduce cytological effects and has often been overlooked in
cytotoxicity screening, which will be addressed here. The European Union define a nanomaterial
as “A natural, incidental or manufactured material containing particles in an unbound state or as
an aggregate or as an agglomerate, and where for 50% or more of the particles in the number
size distribution, one or more external dimensions is in the range 1-100nm” (European
Commission, 2011). In keeping with this definition it is important to investigate the interaction of
biofluid components with nanoparticles to determine if the chemistry is affected resulting in a
change in size distribution or agglomerative state potential causing the nanoparticles to fall outside
the criteria of a nanomaterial as per the EU definition. The effect of biofluid components on the
size distribution and agglomerative state of AgNP was investigated using dynamic light scattering
analysis and zeta potential analysis. The cell lines chosen were HepG-2 a hepatocellular carcinoma
(liver) and Hep2 an epithelial cell line employed as a control. A cytotoxic profile of AgNP was
carried out using the standard cytotoxic assays 3-(4, 5-Dimethylthiazol-2-yl)-2, 5diphenyltetrazolium bromide (MTT) and Alamar Blue (AB) viability assays. A 2’, 7’dichlorofluorescin diacetate (DCFH-DA) plate assay was used to detect any intracellular ROS
generations in response to AgNP exposure.

Materials and Methods
Test materials and reagents
Polyvinylpyrrolidone (PVP) coated silver (Ag) nanopowder of < 100nm Catalogue No: 758329,
was purchased from Sigma-Aldrich Ltd (Dublin, Ireland). PVP coating was confirmed by XRD
analysis. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) Catalogue No:
M5655 and 2’,7’- dichlorofluorescin diacetate (DCFH-DA) Catalogue No: D6883 as well as cell
culture media, supplements and trypsinisation solution were all purchased form Sigma-Aldrich
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Ltd (Dublin, Ireland). Alamar blue (AB) was purchased from Biosciences (Dublin, Ireland).
UDCA, CA and DCA were purchased from Sigma-Aldrich (Dublin, Ireland).

Cell culture
HepG-2 cells (ATCC: HB-8065) an immortalized hepatocellular carcinoma cell line and Hep2
(ATCC: CCL-23) a cell line of laryngeal origin were employed in this study. HepG-2 cells were
cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) with 2mM L-glutamine, sodium
pyruvate and supplemented with 10% foetal bovine serum (FBS) at 37°C in humidified 5% CO2.
Hep2 cells were cultured in RPMI-1640 medium supplemented with 10% FBS, 45 IU/ml penicillin
and 45 IU/ml streptomycin at 37°C in humidified 5% CO2. All cell culture media including FBS
other reagents and supplements are from Gibco purchased through Biosciences (Dublin, Ireland).

Characterization of nanoparticles
Prior to the cytotoxicity testing, pristine AgNP and AgNP in various dispersions in the presence
of each biofluid component were characterized. The suspensions of AgNP were prepared in
deionised water (dH2O), DMEM and RPMI media using a bath-sonicator for 20 minutes (DegussaNey ULTRAsonik 57X 50/60 Hz, California, USA) prior to size and zeta potential analysis.
Dynamic light scattering and zeta potential measurements were performed with the aid of a
Malvern ZetaSizer Nano ZS (Malvern Instruments, Worcestershire, UK) operating with version
5.10 of the systems Dispersion Technology Software (DTS Nano). For size measurement
DTS0012 disposable sizing cuvettes were used. The samples were equilibrated at 25°C for 2
minutes before each measurement. For zeta potential analysis, DTS1060T clear disposable zeta
cells were used and measurements were performed with the automatic model setting, using a
voltage of five to minimize artefacts and charring of media proteins during analysis.
Scanning Electron Microscopy (SEM) was also employed to estimate nanoparticle size from the
images produced by this technique. A Hitachi SU 6600 FESEM instrument was used to obtain
images of the AgNps. First the SEM was calibrated with Au on Carbon standard provided by Agar
Scientific (Essex, UK). Samples were prepared by dispersing particles in ethanol by sonication
750 watts Ultrasonic Processor tip (Branson Ultrasonics, Ultra sonic processor VCX-750W) at
40% amplitude for a total of 45 seconds. Samples were spin coated onto pure silicon wafer which
had been thoroughly cleaned by sonication in acetone for 30 minutes followed by boiling in
propanol for 30 minutes. Silicon wafers were then left to air dry in a dust free environment and the
nanoparticle sample was then spin coated onto wafers 24 hours prior to measurement.
The specific surface area of AgNP was established with a Micrometrics GEMINI BET. BET
sample holders were filled with a known mass of powdered nanoparticles and measured. The
sample was degassed for two hours at room temperature with nitrogen gas prior to analysis.
Nitrogen gas was used as the absorptive gas and a multipoint method was used in the estimation
of specific surface area.
Cytotoxic evaluation
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The AB and MTT assays were performed for assessment of cytotoxicity of AgNP to the three cell
lines. The test used a range of eight concentrations of AgNP (3.91-500µg/ml) in which effects
were likely to occur, this in turn allowed inhibitory concentration (IC50) to be calculated. In all
cases results were compared to an unexposed control (cells in culture media only), eliminating any
dependence of the cell line exposures on well type, seeding efficiency and numbers, exposure
times and volumes. A stock suspension of AgNP was prepared aseptically from which different
concentrations of nanoparticles were prepared in the respective HepG-2 and Hep2 cell media
followed by sonication (Branson Ultrasonics, Ultra sonic processor VCX-750W, maximum
amplification 40%). As a positive control 10% DMSO was prepared in the respective media. For
cytotoxic analysis of nanoparticles in the presence of biofluid components, a range finding
experiment was performed to determine concentration of interest for the definitive experiment. A
stock solution of this test concentration was prepared for each biofluid component, UDCA, CA
and DCA, in the appropriate cell media. A dose finding experiment for each bile acid was
performed in the respective cell lines to determine a working concentration for cytotoxic studies.
The working concentration was noted to have no cytotoxic effect when exposed to cells alone.
Based on the dose finding experiments and previous studies concentrations of 50µM, 1mM and
0.125mM were prepared for UDCA, CA and DCA respectively and a concentration of 2.2 x 107
M UDCA was prepared for Hep2 cell line (Arisawa et al, 2009). Using this solution of each
biofluid component, a stock dispersion of AgNP was prepared aseptically from which a range of
nanoparticle concentrations was prepared. For all assays and exposure scenarios fresh nanoparticle
suspensions were prepared for each experiment.

Alamar Blue assay
For the AB assay, cells were seeded in 96 well microtitre plates (Nunc, Denmark) at a density of
1 x 10⁵, 5 x 104, 4 x 104 and 3 x 104 cells/ml for 24, 48, 72 and 96 hour exposures respectively in
100µl of cell culture media containing 10% FBS. At least three independent experiments were
conducted with six replicate wells employed per concentration per plate in each independent
experiment. After 24 hours of cell attachment, plates were washed with 100µl/well PBS and treated
with increasing concentrations of AgNP prepared in media for 24, 48, 72 and 96 hours. All
incubations were performed at 37°C in a 5% CO2 humidified incubator. The assay was performed
according to manufacturer’s instructions. Briefly, control media and test exposures were removed,
cells were rinsed with 100µl PBS and 100µl of AB solution (5% [v/v] solution of AB) prepared in
fresh media with no added supplements were added to each well. After 3 hour incubation AB
fluorescence was measured at excitation and emission wavelength of 531nm and 595nm
respectively in TECAN GENios (Grodig, Austria). Wells containing AB solution and media only
were used as blanks. For this assay the mean fluorescence units for six replicate cultures were
calculated for each exposure treatment. Acellular studies were performed with test particles and
the AB dye to confirm no interference of the particle with dye conversion (Gupta Mukherjee et al,
2012).

MTT assay
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As with the AB assay a parallel set of three plates were set up for the MTT assay, seeded and
exposed as previously described. After the same exposure times as AB assay, 24, 48, 72 and 96
hours, test medium was removed. Cells were washed with 100µl PBS and 100µl of freshly
prepared MTT solution (5mg/ml MTT in media {without supplements}) was added to each well.
After 3 hour incubation the solution was removed, cells were rinsed 100µl PBS and 100µl MTT
fixative (DMSO) was added to each well. Plates were shaken at 240rpm for 10 minutes. Following
this step the supernatant was removed and transferred to a new 96 well plate for analysis as it has
been observed that sedimentation of AgNP on the bottom of wells interferes with absorbance
readings producing higher values. Absorbance was read at 595nm in TECAN GENios (Grodig,
Austria). Acellular studies were performed with test particles and the AB dye to confirm no
interference of the particle with dye reduction (Gupta Mukherjee et al, 2012).

Reactive Oxygen Species (ROS) studies
Intracellular oxidative stress was quantified using a 2’, 7’-dichlorofluorescin diacetate (DCFHDA) plate assay to detect intracellular hydroperoxides and probe for a wide range of ROS.
Confluent cells were trypsinized and seeded at a density of 1 x10⁵ cells/ml prepared in media, onto
96 well black bottomed plates (Nunc, Denmark) and allowed to attach for 24 hours. Six
independent experiments were performed with six replicate wells for negative control, positive
control and test concentrations on each plate. A working stock of 20µM DCFH-DA in PBS was
prepared and all test concentrations, positive and unexposed negative controls were prepared in
this working stock and exposed to cells. The negative control consisted of 20µM DCFH-DA in
PBS only, the positive control was 5µM hydrogen peroxide (H2O2) prepared in DCFH-DA/PBS
working stock and the AgNP test concentrations (3.91-500µg/ml) together with the AgNP-biofluid
component test concentrations were prepared in the DCFH-DA/PBS working stock. Prior to
cellular testing, acellular studies were performed with the test particles and the DCF dye at all test
scenarios to confirm no reduction of the dye due to AgNP interference. No reduction of DCFHDA by AgNP was noted (Gupta Mukherjee et al, 2012).
After 24 hours of attachment, the media was removed and wells were washed with PBS,
100µl/well. Cells were then treated with 100µl of positive control, negative control and test
concentrations and plates are incubated for 15min, 30 min, 1hr, 2hr, 3hr, 4hr, 5hr and 6hr. The rate
of intracellular ROS production was monitored at each time point by the emission of DCFH-DA
at 529nm by excitation at 504nm at the various time points (plates were re-incubated after each
time point reading). Readings were performed on a TECAN GENios plate reader (Grodig,
Austria).

Confocal Microscopy
Confluent cells were trypsinized and at a concentration of 1 x 105 cells/ml, 100µl of cell suspension
were seeded onto 35mm glass bottom dishes (MatTek Corporation, Ashland, MA, USA). Glass
dishes were incubated for 1 hour. Following incubation 1ml of cell culture media was added to
cell suspensions. Dishes were re-incubated and allowed to attach for 24 hours. A working stock of
10µM CM-H2DCFDA (Molecular Probes- Invitrogen, California, USA) was prepared in DMSO.
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A stock suspension of AgNP was prepared aseptically from which different concentrations of
nanoparticles were prepared in cell media followed by bath-sonication (Degussa-Ney
ULTRAsonik 57X, California, USA). As a positive control, 10% DMSO was prepared in the
respective media. The negative control consisted of cell culture media only.
After 24 hours of attachment, media was removed and glass dishes were washed with PBS
1ml/dish. Cells were treated with 100µl of CM-H2DCFDA and incubated for 30 minutes. After
incubation, dishes were washed in PBS 1ml/dish. 1ml test concentrations, negative and positive
controls were added to dishes and incubated for 1 hour. After incubation dishes were washed in
PBS 1ml/dish and imaged immediately. Images were taken on a Zeiss 510 LSM confocal
microscope with an external argon ion laser source of 488nm excitation and using a bandpass filter
of 505-530nm to detect the fluorescent DCF dye.

Statistical analysis
At least three independent experiments were performed for each cytotoxicity endpoint. Results for
each assay were expressed as a percentage of unexposed control ± standard deviation with control
values set as 100%. Statistically significant differences between samples and their respective
controls were calculated using the statistical analysis package InStat. Statistically significant
differences were set at p<0.05. Normality of data was confirmed with Q-Q percentile plots and
Kolmogorov-Smirnov tests. Equality of variances was evaluated using Levène tests. One-way
analysis of variances (ANOVA) followed by Dunnett’s multiple comparison tests were carried out
for normally distributed samples with homogeneous variances. Non-parametric tests, namely
Kruskal-Wallis followed by Mann-Whitney-u-tests were applied to samples without normal
distribution and/or inhomogeneous variances. Cytotoxicity data (where appropriate) was fitted to
a sigmoidal curve and a four parameter logistic model used to calculate the Inhibitory
Concentration (IC50) values. The IC50 value refers to a concentration of a compound where a 50%
effect is observed in this case a reduction in cell viability. IC50 values were reported as ±95%
confidence intervals. IC50 values were estimated using XLfit3™, a curve fitting add on for
Microsoft® Excel (ID Business Solutions, UK).

Results
Particle characterization
The methods of particle characterization employed to determine the relative size of AgNP as
purchased and in various suspensions were Scanning Electron Microscopy and Dynamic Light
Scattering. Figure 1 shows SEM analysis of a dilute sample of AgNP. This sizing method was
performed on pristine particles as purchased from Sigma-Aldrich (Catalogue No: 758329). In order
to obtain an accurate size reading a sample number of particles (eg. 100 particles) were chosen and
their average size determined. SEM revealed spherical particles with an average particle size of
30nm. This method reflects the physical particle diameter of the pristine particles as purchased. In
a study published by Gupta Mukherjee et al (2012) SEM analysis determined a diameter of <50nm
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for the same Sigma-Aldrich AgNP employing the same preparation method for SEM analysis as
this study (Gupta Mukherjee et al, 2012). While this method of particle sizing provides useful
information on the pristine AgNP, it does not represent how particles will be presented to
biological systems upon entering the body and how the various biofluids they come into contact
with may affect them. While SEM analysis provides a fast analysis of nanoparticles with a simple
sample preparation, analysis of biological samples by this method requires fixation and any change
in nanoparticle size due to interaction with biological material cannot be monitored by this method.
DLS analysis will allow monitoring of the system AgNP are suspended in and provide data on
particle hydrodynamic radius and any change that occurs due to the presence of certain biological
material, in this case protein components of cell culture media and biofluid components.

DLS size measurements were performed on pristine AgNP suspended in dH2O and cell culture
media with and without the addition of the tested biofluid components to the media. Three
concentrations of AgNP were chosen for DLS analysis the highest concentration in which particles
were dispersed, 62.5µg/ml, a low concentration where particles were still visible when dispersed,
3.9µg/ml and a concentration in between 15.6µg/ml. DLS data from this study is illustrated in
figure 2 (a)-(d). When suspended in a biological media the various proteins within that media can
associate with any nanoparticles present and it is postulated that this protein coating can determine
the response of biological systems rather than the particles themselves (Lynch et al, 2007). It can
be assumed that any protein association that occurs in the nanoparticle dispersions presented here
may impact the hydrodynamic radius of particles and cause possible agglomeration.

The concentration of 15.6µg/ml was chosen as a representative concentration between a high and
low concentration of AgNP, it is also a concentration at which an effect on cells is observed as
will be discussed later. From DLS analysis, particle size in dH2O was determined to be 34nm ±SD
3.5nm. A shift in hydrodynamic radius was observed in preparations of AgNP in RPMI. Dispersed
in RPMI alone there are two clear peaks observed one representing RPMI itself and the other at
approximately 40nm representing AgNP. Upon addition of UDCA to the dispersion it does not
appear to have an effect on the hydrodynamic radius. The two peaks are still observed with only a
slight increase in size distribution. This variation may be explained by a shift in the plane of shear
upon addition of UDCA as UV-Vis spectroscopic analysis demonstrated no significant interaction
of AgNP with the cell culture media components. In the presence of DMEM there is shift in the
distribution of AgNP compared to their dispersion in dH2O. The first peak remains relatively
unchanged apart from a reduced number of particles falling within this size range. The second
wider peak demonstrates the greatest change with the majority of particles falling within this size
range which has shifted to below 100nm. However upon addition of UDCA, CA and DCA (figure
(b) – (d)) significant changes are noted with only one peak between 1-10nm observed which was
attributed to DMEM. Ursodeoxycholic acid, cholic acid and deoxycholic acid have a large size
distribution (greater than 200nm) and may result in the formation of large agglomerates with
nanoparticles, causing them to precipitate out at an elevated rate preventing their detection by DLS
analysis resulting in the detection of DMEM only. Further investigation is required into why these
particular dispersions of AgNP and biofluid components cannot be detected by DLS analysis and
how this will ultimately affect their toxicological testing.
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The UV-Vis absorption analysis of the different preparations of AgNP and cell culture media
demonstrated no significant changes to the spectra. No alterations in spectra were noted suggesting
that secondary toxicity caused by nutrient depletion would be unlikely.
Zeta potential analysis, illustrated in Table 1, was performed using the same sample preparations
as for sizing analysis. Typically values above 30mV or below -30mV indicate stability of the
overall system. Zeta potential analysis of AgNP dispersed in dH2O showed instability of particles
at all test concentrations which is unexpected as the particles purchased are PVP coated. When the
particles were dispersed in the test media differences were noted and the AgNP in RPMI
demonstrated stable results, whereas interestingly dispersion of AgNP in DMEM was revealed to
be unstable. Upon the addition of the bile components CA, DCA and UDCA however the system
was also found to be unstable. The large values noted when particles are dispersed in media and
media with biofluid components would suggest a tendency to repel each other and as such reduce
the likelihood of agglomeration (Xia et al, 2006). It can be assumed from the data that the addition
of biofluid components does not modify the overall stability of the system.
BET analysis was also employed to determine surface area of pristine powder and yielded a surface
area of 2.3 ± 0.1 m2/g.

Cytotoxicity Testing
Viability assays were performed to determine the effect of AgNP exposure to HepG-2 and Hep2
cell lines. The ability of the biofluid components UDCA, CA and DCA to modify the toxic
response of AgNP was also evaluated. Cytotoxicity data for AgNP exposure in the HepG-2 and
Hep2 cell lines are presented in table 2. The results of the MTT assay are presented for each cell
line in the presence and absence of the respective biofluid component. Both MTT and AB assays
were performed for each cell line. Results for AB assay are not shown.

Cytotoxic evaluation HepG-2 cell line to AgNP exposure alone and in the presence of UDCA,
CA and DCA
Figure 3 represents the cytotoxic response of HepG-2 cells to AgNP exposure determined by the
MTT assay. In the presence of AgNP cell viability decreases in a dose and time dependent manner,
with a substantial decline in mitochondrial integrity detected at concentrations of 15.6µg/ml and
above. A significant decrease in cell survival occurs at concentrations of 15.6µg/ml after 48 hour
exposure while a significant reduction in cell viability at all exposure time points occurs at AgNP
concentrations of 31.25µg/ml and upwards.
A DCF-DA plate assay was employed to detect any ROS production in response to AgNP exposure
over a 24 hour period. Readings were taken every hour for 6 hours. Following this
readings were then taken at 12 and 24 hours to detect any delayed intracellular ROS production in
response to increasing concentrations of nanoparticle exposure. Figure 4 illustrates ROS
generation in response to AgNP exposure. The study shows that the amount of ROS produced
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increases with increasing length of nanoparticle exposure and also with increasing concentration.
ROS production was noted at concentrations of 7.8µg/ml and above after 15 minutes exposure and
was seen to increase with dose and exposure time. The greatest level of ROS production was
observed at a concentration of 500µg/ml after 12 hours of exposure. A reading at 24 hours shows
a decline in ROS production compared to the 12 hour time point which can be associated with cell
death. Confocal microscopy was employed to confirm ROS induction due to AgNP exposure at a
concentration of 31.25µg/ml in figure 5.

Figures 6 and 7 show the toxic response of AgNP to HepG-2 cells, but in the presence of UDCA.
The same dose dependent response was noted as with the previous assays, following exposure to
AgNP alone with this response increasing over time. The MTT assay (figure 6) showed a
significant decline in cell viability after 96 hours at a concentration of 7.81µg/ml. At a 15.6µg/ml
concentration of AgNP a significant decrease in viability is observed following 48, 72 and 96 hour
exposures. It was only at concentrations of 31.25µg/ml and above that a significant reduction in
cell survival is seen at all exposure time points. Interestingly the presence of UDCA appears to
have had no effect on cellular response to AgNP exposure, with almost identical patterns of toxicity
observed both with and without the addition of UDCA. This suggests that the presence of UDCA
does not modify AgNP toxicity.

In the presence of UDCA (figure 7) a similar pattern of ROS production was observed as with the
AgNP exposure alone although it appears more erratic with larger error bars. The same dose and
time dependent response was observed with ROS induction detected following 15 minute exposure
at concentrations as low as 3.91µg/ml. A similar trend was observed with ROS induction in the
presence of AgNP alone and a maximum ROS production was observed at a concentration of
500µg/ml after 12 hour exposure. Following 24 hour exposure ROS production was seen to
decline, again this can be attributed to cell death. ROS induction by a concentration of 31.25µg/ml
AgNP was confirmed by confocal microscopy illustrated in figure 8. It is apparent from the data
that UDCA does not alter oxidative stress induced by AgNP exposure and it can be concluded that
UDCA does not mediate AgNp ability to induce intracellular ROS production.

Figure 9 represents the exposure of HepG-2 cells to AgNP in the presence of cholic acid (CA).
Again a dose and time dependent response to AgNP exposure was observed with this assay. A
noted decline in cell viability can be seen after 24 hours of exposure at an AgNP concentration of
3.91µg/ml and then an apparent increase in viability compared to the unexposed control after
longer exposure periods at the same concentration, indicative of a possible cell recovery. At an
AgNP concentration of 3.91µg/ml after a 24 hour exposure a significant decline in cell viability is
apparent. At exposure times of 48 and 72 hours a significant decline in viability was also observed
when compared to the unexposed control. At 15.6µg/ml and above significant reduction in cell
survival could be seen at all exposure concentrations when compared to the unexposed negative
control. As observed with UDCA, the addition of CA does not appear to modify the toxicity of
AgNP and the response in the presence of CA is seemingly identical, with no significant difference
or change between the two.
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Further studies were performed with the DCF-DA plate assay to determine the ability of AgNP
with addition of CA to induce oxidative stress. Figure 10 demonstrates ROS production in a dose
and time dependent manner. Generation of ROS is seen at the higher concentrations of AgNP 125,
250 and 500µg/ml. Induction of intracellular ROS was noted after 15 minutes of exposure
compared to the unexposed control with the highest generation detected after this time and at the
highest AgNP concentration 500µg/ml. After 15 minutes of exposure ROS production begins to
decline in a step-wise pattern as exposure time progresses with no ROS detected after the 4 hour
exposure point. In comparison to HepG-2 exposure to AgNP alone, the addition of CA alters the
pattern of ROS production. In the presence of CA, ROS induction occurs almost immediately after
exposure to AgNP and then declines rapidly compared to earlier time points with no ROS detected
after 4 hours. Induction of ROS only occurs at the higher exposure concentrations 125, 250 and
500µg/ml. Exposure to AgNP alone results in a much lower percentage of ROS induction
compared to the unexposed control that increases over time and only begins to decline after 12
hours of exposure. In the presence of CA induction of ROS occurs much quicker but declines at a
similar rate whereas in the presence of AgNP only ROS production is more sustained over time.
Conformation of ROS induction by AgNP at a concentration of 3.91µg/ml in the presence of 1mM
CA was verified by confocal microscopy as illustrated in figure 11.
Figure 12 illustrates the toxic response of HepG-2 cells to AgNP exposure in the presence of
deoxycholic acid (DCA). As can be seen in figure 9 a loss in mitochondrial integrity is
demonstrated at the lowest AgNP concentration of 3.91µg/ml at all exposure time points.
Significant loss is seen at a concentration 3.91µg/ml after 24 hour exposure. There is significant
reduction at this concentration after 72 and 96 hour incubations but not after 48 hour incubation
again this may be due to cell recovery. As the AgNP are in low doses it is possible they have fallen
out of solution at this time and any effect was induced within the first 6-12 hours following
exposure. After this point any surviving cells may be starting to recover and replicate. The same
pattern is observed at a concentration of 7.81µg/ml. A significant reduction is observed at all
exposure time points from a concentration of 15.6µg/ml and above.

The induction of ROS upon exposure to AgNP with the addition of DCA (figure 13) follows a
similar pattern to that observed with the addition of CA. However it can be seen that ROS are
induced at much lower concentrations of AgNP when compared to the CA and in the presence of
AgNP alone. ROS were detected after 15 minutes at a concentration of 31.25µg/ml and higher
with maximum ROS production occurring at 500µg/ml after a 15 minute exposure. After 15
minutes ROS levels begin to decline with increasing exposure time. When compared to exposure
of HepG-2 cell to AgNP alone the observed ROS induction occurs at lower concentrations of
AgNP and does not increase with time but begins to decline after 15 minutes. Indeed to the case
of CA, where ROS induction occurs much earlier but is short lived. It appears that AgNP exposure
in the presence of DCA results in the greatest ROS induction compared to the unexposed control
and at lower doses when compared to the AgNP exposure with CA and AgNP exposure alone.
Confirmation of ROS induction by AgNP at a concentration of 3.91µg/ml in the presence of
0.125mM DCA is confirmed by confocal microscopy as illustrated in figure 14.
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The AB assay was also performed for the HepG-2 cell line in the presence and absence of UDCA,
CA and DCA where a dose and time dependent response was also observed resulting from AgNP
exposure. AB gives a more general picture of the loss in cell viability by targeting the cytosol of
the cell and detecting a change in the cytosolic environment. A similar pattern of toxicity was
observed with the addition of DCA having a substantial effect on cell viability occurring after 24
hours of exposure (data not shown).
Statistical analysis (p<0.05) comparing the differences in toxicity induced by AgNP alone and in
the presence of the tested biofluid components highlighted statistically significant differences
between the toxicological data. The presence of CA and DCA significantly altered the cytotoxic
effect induced by AgNP on HepG-2 cells at a concentration of 15.6µg/ml and above the response
curves were found to be statistically (p<0.05) different. This change was noted at 48, 72 and 96
hour time points. UDCA was noted not to significantly alter the toxicity of AgNP in HepG-2 cells.

Cytotoxic evaluation of Hep2 cell line to AgNP exposure alone and in the presence of UDCA
As a control, another cell line was tested to establish if biofluid components could modify the
effects of AgNP exposure in areas other than their target organs. To investigate this, the Hep2 cell
line was selected. The same exposure concentrations were employed and the effects of AgNP
toxicity in the presence of biofluid components were investigated. UDCA was chosen as the test
bile acid. A dose finding experiment was performed to determine the highest concentration of
UDCA that the Hep2 cell line could withstand without causing toxicity. This concentration was
found to be 2.2 x 10-7 M and this is the working concentration that was employed for the following
experiments.
Figure 15 displays the cytotoxic response of Hep2 cells to AgNP exposure determined by the MTT
assay. This assay demonstrates a typical dose and time dependent pattern with significant reduction
in cell survival is seen at all concentrations following 72 hour exposure. A significant reduction in
viability after 72 and 96 hours was observed at doses of 7.81µg/ml and above and after 48 hours
at a concentration of 31.25µg/ml and above. Furthermore a significant decrease in cell survival
compared to the unexposed control was observed for all exposure time points at a concentration
of 62.5µg/ml and above.

Figure 16 illustrates the toxic response of AgNP to Hep2 cells in the presence of UDCA. The data
demonstrate that in the presence of UDCA there is a dramatic reduction in cell viability compared
to when cells are exposed to AgNP alone. No significant change in cell viability occurs after 24
hour exposure but a significant reduction following 48, 72 and 96 hour exposures was noted at all
tested concentrations of AgNP. The data presented illustrates that compared to AgNP exposure
alone the presence of UDCA does mediate toxicity.
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A DCF-DA plate assay was also employed to investigate intracellular oxidative stress, to see if the
presence of UDCA could influence the generation of ROS in response to AgNP exposure.
Exposure to increasing concentrations of AgNP induced ROS production in a dose and time
dependent manner (figure 17). ROS production was detected at exposure concentrations of
7.81µg/ml and above with maximum production seen at 500µg/ml. Induction of ROS was
observed after 15 minutes of exposure with maximum production observed after 1 hour after which
levels of detectable ROS began to decline. In the presence of UDCA (figure 18) a substantial
reduction in ROS generation was observed when compared to exposure to AgNP alone and ROS
were only detected at higher concentrations of AgNP above 250µg/ml. A maximum level ROS
production with added UDCA was observed at a concentration of 500µg/ml after 1 hour and as
illustrated by the data the percentage of ROS induction when compared to the negative control is
substantially reduced compared to the amount generated in the absence of UDCA.
The AB assay was also performed for the Hep2 cell line in the presence and absence of UDCA
where a dose and time dependant response was also observed resulting from AgNP exposure. A
similar pattern of toxicity was observed with the addition of UDCA having a substantial effect on
cell viability occurring after 24 hours of exposure (data not shown).
Statistical analysis (p<0.05) comparing the differences in toxicity induced by AgNP alone and in
the presence of UDCA in Hep2 cells highlighted statistically significant differences between the
toxicological data. A significant effect on toxicity was noted in the presence of UDCA from the
lowest test concentration up to 250µg/ml after 48 and 96 hour time points compared with exposure
to AgNP alone.

Discussion
It is clear from the literature that exposure to nanoparticles is becoming more widespread mainly
due to their continued incorporation into various consumer products. Upon exposure, nanoparticle
contact with surfactants and biofluids is inevitable and it is important to take these events into
account when examining toxicity. This study aimed to investigate this interaction to identify a
possible modification of toxicity by individual components of one of the major biofluids within
the body.
The physiochemical characteristics of AgNP play an important role in how they will interact with
biological systems. The size, associated surface area, shape and chemical composition have all
been shown to be of great importance to nanoparticle toxicity. Size influences surface area which
leads to greater cell contact, while truncated triangular nanoparticles show increased toxicity
compared to spherical nanoparticles and it is believed that cylindrical particles can cross the cell
membrane easier than other shapes due to their ability to harness the clatherin machinery (Renwick
et al, 2004; Rai et al, 2009; Kam et al, 2004).
It is now well established that upon entry into the body nanoparticles almost immediately become
coated in protein and that this adsorbed layer or “corona” is important in biological responses to
nanoparticle exposure (Gray, 2004; Lynch & Dawson, 2008). While there will be adsorption of
the proteins of biofluid components and cell culture media onto the nanoparticle surface, it can be
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assumed that these proteins will associate and dissociate from AgNP at different rates depending
on a factors such as concentration and affinity (Lynch et al, 2007).
Proteins tend to agglomerate upon dispersion in an aqueous solution and may coat AgNP trapping
them within agglomerates increasing the rate at which they fall out of solution. A number of studies
have investigated this dispersion to determine how this affects overall toxicity. It is known that
nanoparticles once suspended in cell culture media can precipitate out of solution and agglomerate
at different rates. As such this raises a number of questions relating to dosimetry and the effect of
agglomerate formation on the end result of nanoparticle exposure. As well as influencing the
results of toxicity it can also influence exposure times as agglomerate formation and precipitation
may increase the time taken for delivery of the full dose to cells. Further investigation is required
to develop a method of including dosimetric parameters into toxicological testing so that accurate
results for in vitro assays can be obtained that are comparable to animal models (Cohen et al, 2014;
Cohen et al, 2013; Kroll et al, 2009; Teeguarden et al, 2007).
Zeta potential analysis was also performed and a change in values would indicate interaction of
nanoparticles with biofluid components and cell culture media, suggesting indirect toxicity caused
by their interaction (Casey et al, 2007; Casey et al, 2008). No change on overall stability was noted
following biofluid component addition. The overall particle stability also influences size and
agglomerative state. Larger unstable zeta potential values were noted for AgNP dispersions in
media with biofluid component addition. These large values suggest particles will repel each other
reducing the potential to agglomerate. The dispersant plays a role in particle stability thus effecting
size and possible agglomeration (Xia et al, 2006).
A recent study demonstrated that AgNP exposed to synthetic stomach fluid led to transformations
in the particles including particle aggregation, changes in particle morphology and the release of
silver ions (Mwilu et al, 2013). It was suggested that alterations to AgNP size and surface
properties due to exposure to synthetic stomach acid may impact on their transformation through
the gastrointestinal tract and may in turn influence AgNP interaction with the cells they encounter.
The binding of proteins be it from cell culture media or biofluid components can aid in the binding
of particles to cell surfaces, their trafficking through biological systems and the resulting effects
will also be altered. Very recently in a study by Wang et al (2013), the protein surface coating or
“corona” was identified as providing a Trojan horse effect to nanoparticles. Initial entry of
nanoparticles into the cell did not cause immediate toxicity, it was only when the nanoparticles
were transported to the lysosome and the corona was degraded in the acidic environment that
toxicity was observed. At this point, much later after initial exposure, loss of lysosomal integrity
and release of its contents was observed followed by cell death via apoptosis (Wang et al, 2013).
These findings can be related to the work undertaken in this study as biofluid components are
protein entities and will ultimately form part of the protein corona and may contribute to particle
interactions with living systems and any related toxicity.
This reiterates the importance of performing realistic exposure scenarios in toxicological testing
to determine nanoparticles interactions in biological systems. These results highlight the
importance of establishing the physiochemical characteristics of AgNP in a variety of biological
suspensions as their interactions with these components influence their interactions with cellular
components and biological systems and will ultimately determine their distribution throughout the
body and the signalling pathways and end responses they induce.
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The cytotoxicity studies undertaken illustrate that mitochondrial integrity (MTT) and the general
health of the cell (AB) is affected by exposure to AgNP and that the chosen biofluid components
have different modifying effects. Table 2 concisely illustrates IC50 values for both assays providing
an overall synopsis of toxicity. From the data presented it can be suggested CA and DCA do have
some modifying effects. While not altering the pattern of toxicity in the viability assays, the pattern
of ROS induction is altered upon their addition. The addition of CA and DCA induces greater
levels of ROS induction with DCA producing the greatest response following a 15 minute
exposure at the highest concentration of AgNP compared to the unexposed control. AgNP
exposure alone produces much lower levels of ROS with maximum values only slight higher
compared to the unexposed control. This increase in ROS production and at earlier points of
exposure may suggest a more rapid or alternative pathway of cell death in the presence of CA and
DCA. Previous studies have shown that lipid peroxidation by nanomaterials is a contributing factor
to the generation of ROS and the overwhelming of natural antioxidant systems. ZnO is noted as
enhancing lipid peroxidation contributing to increased ROS generation while AgNP exposure in
rats can cause increased lipid peroxidation and quench naturally occurring antioxidants. It is
postulated that the increased levels of ROS following AgNP-CA and AgNP-DCA exposure
enhances lipid peroxidation within cells resulting in the greater levels of ROS noted compared to
AgNP exposure alone (Premanathan et al, 2011; Adeyemi & Faniyan, 2014). This upsurge in
generation may be the result of a reactive product formed by the interaction of AgNP and biofluid
components. Further investigation into the mechanism of cell death and the potential role of lipid
peroxidation within cells must be investigated.
While no modification in toxicity by UDCA was noted in the HepG-2 cell line, modification was
noted in Hep2 cells. A delay in toxicity in the first 24 hours after exposure together with a reduction
in ROS production strongly suggests that UDCA can modify Hep2 toxic response to AgNP
exposure. While it appears to increase AgNP toxicity, ROS induction is significantly reduced
suggestive of an antioxidant effect. This may indicate an alternative mechanism of cell death.
These data indicate that UDCA can modify AgNP toxicity in a cell type different from that of its
normal target.
While it is clear AgNP cause toxicity, it must be considered how much of this toxicity is attributed
to the release of silver ions. A recent study by Beer et al (2012) addressed this phenomenon,
identifying to what level the fraction of silver ions in various AgNP suspensions (commercially
available and laboratory synthesized) influence toxicity (Beer et al, 2012). The study concluded
that free silver ions in AgNP preparations do indeed play a considerable role in the overall toxicity
of AgNP suspensions. However other studies are in agreement that at lower concentrations of
metal ions, the uptake of nanoparticles leads to additional toxicity compared to higher
concentrations where it appears the particles do not contribute to further toxicity (Navarro et al,
2008; Kim et al, 2009). Beer et al (2012) postulate that the mechanism of toxicity for AgNP is
dissolution of particles in lysosomes, previously observed for copper oxide (CuONP)
nanoparticles, possibly due to a protective barrier effect of the plasma membrane but this barrier
can be evaded by a Trojan horse mechanism when nanoparticles are taken up by cells (Studer et
al, 2010; Limbach et al, 2007). It must also be considered that sonication of AgNP suspensions
and other preparation methods may have contributed to silver ion release and therefore toxicity.
For example during sonication the energy released in order to break up large AgNP aggregates is
converted to thermal energy which may promote dissolution of silver ions from particles (Liu &
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Hurt, 2010). From this information it is clear that when investigating AgNP toxicity, the role of
both silver ions and the particles themselves must be considered.
In order to monitor the potential mediation of the chosen biofluid components on AgNP toxicity
in cells found outside of their normal target area, an epithelial laryngeal cell line was chosen. The
biofluid components under study have been employed as pharmaceutical agents and medications.
UDCA is widely used as a method of gallstone dissolution (Arisawa et al, 2009; Lapenna et al,
2002). This treatment has numerous trade names, including Actigall™ and BILIVER™, and is an
oral treatment presented as an alternative to surgery. Cholic acid and deoxycholic acid also have
medical applications. Cholic acid is used as treatment for children and adults with inborn errors in
bile acid synthesis. Orphacol™ as it is known is taken orally and is vital in preventing the
development of cholestatic liver disease (European Medicines Agency, 2013). Deoxycholic acid
also has uses as a therapeutic drug used to treat localized fat deposits via subcutaneous injection.
Studies have also reported the conjugation of heparin to deoxycholic acid in order to develop an
oral delivery system for anticoagulant treatment preferable to the standard intravenous and
subcutaneous injection (Lee et al, 2001; Kim & Vaishali, 2006). The fact that these bile acids are
or may be utilized in a medicinal capacity highlights that they will be present in areas of the body
other than the liver. As such the data presented here on a laryngeal cell line is a relevant line of
investigation given that in most cases these bile acid derived treatments are given orally. As the
data demonstrate, the effect on toxicity in cell lines of different origins must be seriously
considered and a more complete cytotoxic profile of AgNP to include exposure site contributions
be established.

Conclusion
The data demonstrate that biofluid components can significantly influence the toxic profile of
AgNP. As such future studies must consider the effects various biofluids and their components
have on the processing of nanoparticles upon entry to the body, their presentation to cells,
distribution and the biological processes they induce. Finally researchers must not just consider
the toxicity of the isolated nanoparticles but that of a combined effect including, the local
environment and the ions they release which have been shown to contribute considerably to
toxicity.
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Table 1 Table of Zeta Potential results for three concentrations of AgNps 3.91, 15.6 and 62.5µg/ml
dispersed in different cell culture media and in the presence of different biofluid components. Data
expressed as average value ±SD of three individual experiments.
62.5µg/ml

15.6µg/ml

3.9µg/ml

AgNP Only

-15.5 ±1.2mV

-31.2 ± 0.9mV

-22.1 ± 6.6mV

AgNP RPMI

-473.7
±50.8mV

-380 ±
121.1mV

-221 ±
117.2mV

AgNP DMEM

-7.9 ± 5.1mV

1.9 ± 3.4mV

-11.2 ± 7.2mV

AgNP 1mM Cholic Acid DMEM

-7.1 ± 6.9mV

-2.56 ± 3.4mV

-27.6 ± 5mV

AgNP 0.125mM Deoxycholic Acid
DMEM

-4.9 ± 9.8mV

-12.1 ± 5mV

-5.5 ± 8.9mV

AgNP 50µM UDCA DMEM

-6.6 ± 2.3mV

-8.1 ± 6.4mV

-6 ± 5mV
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Table 2 Calculated IC50 values (µg/ml) resulting from exposure to AgNps for the AB and MTT
assays in the HepG-2 and Hep2 cell lines. * Denotes lethal dose less than the lowest exposure
concentration. IC50 values were calculated from the average response of three independent
experiments fitted to a sigmoidal curve and a four parameter logistic model used to calculate
Inhibitory Concentration (IC50) with a (p<0.05)
Cell Line

AB assay IC50 (µg/ml)

MTT assay IC50 (µg/ml)

24hr

48hr

72hr

96hr

24hr

48hr

72hr

96hr

HepG-2

5.5

7.8

5.5

4.2

119.51

45.34

44.59

49.2

HepG-2 + UDCA

6.3

9.1

5.3

5.7

135.06

66.52

31.81

10.97

HepG-2 + CA

4.03

6.24

4.78

7.94

0.0004

0.0003

0.001

215.48

HepG-2 + DCA

4.28

6.49

2.99

6.24

1389.3

746.29

0.002

0.003

Hep2

45.06

31.58

8.8

91.9

388.39

157

2.19

43.41

Hep2 + UDCA

439.16

4.25

0.27

0.94

0.0007

<3.91*

<3.91*

<3.91*
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Figure 1 SEM micrograph at scale bar of 2µm image pristine AgNP dispersed in ethanol to a
concentration of 0.625µg/ml by sonication using Ultrasonic Processor tip.
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(b)
Size Distribution by Number (count)
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(d)
Size Distribution by Number (count)
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Figure 2 (a) – (d) Dynamic Light Scattering size (nm) particle number (count) distribution plot of
AgNP (15.6µg/ml) dispersed in media, dH2O and in the presence of (a) UDCA (RPMI), (b) UDCA
(DMEM), (c) CA and (d) DCA. Data presented is the average of three individual experiments
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Figure 3 Cytotoxicity of AgNP in HepG-2 cells after 24, 48, 72, and 96hr exposures as determined
by the MTT assay. Data expressed as percentage of control mean ± SD of three individual
experiments. * denotes a statistically significant (p<0.01) difference from the unexposed control
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Figure 4 ROS generation in HepG-2 cells after different time points of AgNP exposure. Data
expressed as percentage of control mean ± SD of eight independent experiments.

(a)

(b)

Figure 5 Confocal image (x40) of cells exposed to 31.25µg/ml AgNP suspended in cell culture
media. Image taken on a Zeiss 510 LSM confocal microscope with an argon ion laser, excitation
488nm using a band pass filter 505-530nm to detect DCF. (a) LSM image demonstrating
intracellular ROS, (b) overlay of LSM and brightfield image.
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Figure 6 Cytotoxicity of AgNP in HepG-2 cells with added UDCA after 24, 48, 72 and 96hr
exposures as determined by the MTT assay. Data expressed as percentage of control mean ± SD
of three independent experiments. * denotes a statistically significant (p<0.01) difference from the
unexposed control
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Figure 7 ROS generation in HepG-2 cells after different time points of AgNP exposure in the
presence of UDCA. Data expressed as percentage of control mean ± SD of eight independent
experiments.
(a)

(b)

Figure 8 Confocal image (x40) of cells exposed to 31.25µg/ml AgNP suspended in cell culture
media in the presence of UDCA. Image taken on a Zeiss 510 LSM confocal microscope with an
argon ion laser, excitation 488nm using a band pass filter 505-530nm to detect DCF. (a) LSM
image demonstrating intracellular ROS, (b) overlay of LSM and brightfield image.
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Figure 9 Cytotoxicity of AgNP in HepG-2 cells with added CA after 24, 48, 72, and 96hr
exposures as determined by the MTT assay. Data expressed as percentage of control mean ± SD
of three independent experiments. * denotes a statistically significant (p<0.01) difference from
the unexposed control

29

200
190
180

15min

ROS Induction
(% of control)

170

30min

160

1hr

150

2hr

140

3hr

130

4hr

120

5hr

110

6hr

100
PBS (unexposed
control)

7.8

31.25

125

500

Conc AgNP 1mM Cholic Acid

Figure 10 ROS generation in HepG-2 cells after different time points of AgNP exposure in the
presence of CA. Data expressed as percentage of control mean ± SD of eight independent
experiments.

(a)

(b)

Figure 11 Confocal image (x40) of cells exposed to 31.25µg/ml AgNP suspended in cell culture
media in the presence of CA. Image taken on a Zeiss 510 LSM confocal microscope with an argon
ion laser, excitation 488nm using a band pass filter 505-530nm to detect DCF. (a) LSM image
demonstrating intracellular ROS, (b) overlay of LSM and brightfield image.
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Figure 12 Cytotoxicity of AgNP in HepG-2 cells with added DCA after 24, 48, 72, and 96hr
exposures as determined by the MTT assay. Data expressed as percentage of control mean ± SD
of three independent experiments. * denotes a statistically significant (p<0.01) difference from the
unexposed control
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Figure 13 ROS generation in HepG-2 cells after different time points of AgNP exposure in the
presence of DCA. Data expressed as percentage of control mean ± SD of eight independent
experiments.
(b)

(a)

Figure 14 Confocal image (x40) of cells exposed to 31.25µg/ml AgNP suspended in cell culture
media in the presence of DCA. Image taken on a Zeiss 510 LSM confocal microscope with an
argon ion laser, excitation 488nm using a band pass filter 505-530nm to detect DCF. (a) LSM
image demonstrating intracellular ROS, (b) overlay of LSM and brightfield image.
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Figure 15 Cytotoxicity of AgNP to Hep2 cells after 24, 48, 72 and 96hr exposure as determined
by the MTT assay. Data expressed as percentage of control mean ± SD of three independent
experiments. * denotes a statistically significant (p<0.01) difference from the unexposed control
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Figure 16 Cytotoxicity of AgNP to Hep2 cells with added UDCA after 24, 48, 72 and 96hr
exposures as determined by the MTT assay. Data expressed as percentage of control mean ± SD
of three independent experiments. * denotes a statistically significant (p<0.01) difference from the
unexposed control
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Figure 17 ROS generation in Hep2 cells after different time points of AgNP exposure. Data
expressed as percentage of control mean ± SD of eight independent experiments
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Figure 18 ROS generation in Hep2 cells after different time points of AgNP exposure in the
presence of UDCA. Data expressed as percentage of control mean ± SD of eight independent
experiments
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